Indinavir Perinatal Data

Medical Advocates
Indinavir (Crixivan)

Perinatal Data

FDA Warning
Guidelines
Adverse Events
Efficacy

Indinavir Main Page Main New/Newsworthy Home Page

Last Update: February 06, 2008
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

FDA Warning

Internet Documents

FDA DRUG ALERT
FDA Warning on Use of Indinavir in Pregnant Women
FDA
December 27, 2004
FDA Warning

Prevention/Treatment Guidelines/Recommendations

United States
Internet Documents

FULL TEXT PDF DOCUMENT
Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs
in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce
Perinatal HIV Transmission in the United States.
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

FULL TEXT PDF DOCUMENT
Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Perinatal HIV Guidelines Working Group.
November 2, 2007
Guidelines

Adverse Events

Conference Reports, Abstracts and Posters

POSTER
5-Year Review of Maternal-Fetal Outcomes in Patients Exposed to Indinavir Sulfate
during Pregnancy
K. McGhee, K. Shields, J. Benson, et al.
(9RETRO)

PDF Poster Abstract

Efficacy

Journal Papers, Abstracts, and Commentaries

Antiretroviral therapy with indinavir 400 mg-ritonavir 100 mg twice daily containing regimen
in HIV-1 infected women during pregnancy.
Ghosn J, De Montgolfier I, Corn�lie C, et aL
Antimicrob Agents Chemother. 2008 Feb 4
Abstract

Pharmacokinetics and safety of Indinavir in HIV-infected pregnant women, a PACTG
358 study.
Unadkat JD, Wara DW, Hughes MD, et al
Antimicrob Agents Chemother. 2006 Dec 11
Abstract

Conference Reports, Abstracts and Posters

ART with Indinavir �Ritonavir (400 mg/100 mg Twice Daily)-containing Regimen in HIV-1-
infected Pregnant Women
R Tubiana , S Dominguez C Perot^{(12 CROI)} Abstract

Indinavir Main Page Main New/Newsworthy Home Page

Indinavir Perinatal Data